2008-07-04 20:41:17 - www.companiesandmarkets.com adds new report - Becton, Dickinson and Co - Premium Company Profile

www.companiesandmarkets.com/Summary-Company-Profile/Becton,-Dick ..
Introduction

Becton, Dickinson and Company (BD), a medical technology company, improves drug therapy, enhances the diagnosis of infectious diseases and advances drug discovery. It manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. It serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public



Scope

Contains corporate strategy, value chain

presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies


Highlights

BD’s business includes medical, diagnostics and biosciences segments. The medical segment produces an array of medical devices including safety engineered injection, infusion therapy devices, pre-fillable drug delivery systems, and surgical blades.



The diagnostics segment provides products for the safe collection and transport of diagnostic specimens, and instrumentation for analysis for a range of microbiology and infectious disease testing. The biosciences segment produces research and clinical tools that facilitate the study of cells used to aid in the development of new drugs.



BD’s historical revenues increased at a CAGR of 10% from 3,960 million to $5,835 million over the historical period 2002-2006, primarily due to sales of medical surgical systems that include sales safety-engineered products and prefilled flush syringes.



Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company’s adjusted five year financial data along with key ratios and market capitalization